← Leaderboards
William E. Evans
St. Jude Children'S Research Hospital
$20,051,064
Attributed
$20,051,064
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$20,126,064 · 5
By mechanism
R37$9,672,311 · 1
R01$6,756,120 · 2
P50$3,622,633 · 1
P30$75,000 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Richard James Gilbertson$38,555,720
- Winfred C Wang$3,647,138
- Mary V. Relling$28,942,987
- Arthur W. Nienhuis$5,923,134
- Sean Phipps$3,481,334
Others in their field
Top investigators on “Acute Lymphocytic Leukemia”
- Gregory H Reaman · National Childhood Cancer Foundation$49,776,131
- Markus Mãschen · Yale University$23,102,071
- Mary V. Relling · St. Jude Children'S Research Hospital$19,973,747
- John F Dipersio · Washington University$18,970,493
- Bruce R. Blazar · University Of Minnesota$16,394,527
- James L M Ferrara · Dana-Farber Cancer Institute$15,676,011
Research focus
Acute Lymphocytic LeukemiaMalignant Childhood NeoplasmChildMalignant NeoplasmsPharmacogenomicsVincristineGenomicsPharmaceutical PreparationsCause Of DeathChildhood LeukemiaAntileukemic AgentNewly DiagnosedLeukemia, Lymphocytic, Acute, L1Drug MetabolismPediatric Neoplasm /CancerCellsResearch PersonnelProgramsFundingAwardHuman SubjectChild (0-11)AsparaginaseDrug Resistance
Grant awards (38)
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity$714,178
P50 · FY2019 · GM · contact PI
Pharmacogenomics of Childhood Leukemia ALL$704,703
R01 · FY2019 · CA · contact PI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity$729,420
P50 · FY2018 · GM · contact PI
Pharmacogenomics of Childhood Leukemia ALL$726,520
R01 · FY2018 · CA · contact PI
Pharmacogenomics of Childhood Leukemia ALL$726,540
R01 · FY2017 · CA · contact PI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity$707,707
P50 · FY2017 · GM · contact PI
Pharmacogenomics of Childhood Leukemia ALL$726,561
R01 · FY2016 · CA · contact PI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity$698,840
P50 · FY2016 · GM · contact PI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity$772,488
P50 · FY2015 · GM · contact PI
Pharmacogenomics of Childhood Leukemia ALL$745,108
R01 · FY2015 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$633,969
R37 · FY2014 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$615,910
R37 · FY2013 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$656,917
R37 · FY2012 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$657,865
R37 · FY2011 · CA · contact PI
Cancer Center Support Grant (CCSG)$75,000
P30 · FY2011 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$695,209
R37 · FY2010 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$661,549
R37 · FY2009 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$590,109
R37 · FY2009 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$576,724
R37 · FY2008 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$396,000
R37 · FY2008 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$574,893
R37 · FY2007 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$579,787
R37 · FY2006 · CA · contact PI
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$482,420
R01 · FY2006 · CA · contact PI
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)$584,686
R37 · FY2005 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$481,656
R01 · FY2005 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$496,196
R37 · FY2004 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$469,232
R01 · FY2004 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$481,745
R37 · FY2003 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$475,929
R01 · FY2003 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$3,251
R37 · FY2003 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$467,714
R37 · FY2002 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$416,585
R01 · FY2002 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$454,091
R37 · FY2001 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$405,711
R01 · FY2001 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$68,540
R37 · FY2001 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$38,740
R37 · FY2001 · CA
DRUG METABOLISM IN CHILDHOOD CANCER$438,416
R37 · FY2000 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN$395,155
R01 · FY2000 · CA